Cargando…

Role of maraviroc in a dyslipidemic murine model of atherosclerosis RTV-induced

PURPOSE: Chemokines and their receptors play a crucial role in the development of atherosclerosis. CCR5 is considered to be crucial to monocyte recruitment during development of atherosclerosis. CCR5, known as a co-receptor of HIV-1, is the target of the approved CCR5 antagonist maraviroc (MVC). The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cipriani, S, Mencarelli, A, Francisci, D, Renga, B, Schiaroli, E, D'Amore, C, Fiorucci, S, Baldelli, F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International AIDS Society 2012
Materias:	Poster Abstract – P29
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3552622/ http://dx.doi.org/10.7448/IAS.15.6.18154

Ejemplares similares

The HIV Matrix Protein p17 Subverts Nuclear Receptors Expression and Induces a STAT1-Dependent Proinflammatory Phenotype in Monocytes
por: Renga, Barbara, et al.
Publicado: (2012)

HIV-1 infection is associated with changes in nuclear receptor transcriptome, pro-inflammatory and lipid profile of monocytes
por: Renga, Barbara, et al.
Publicado: (2012)

Nitric oxide protects against HIV gp120 endothelial injury
por: Fiorucci, S, et al.
Publicado: (2010)

Évolution des prescriptions des tests d’hémostase en France et impact de la pandémie COVID-19
por: Bentounes, Nûn, et al.
Publicado: (2023)

VSL#3 Resets Insulin Signaling and Protects against NASH and Atherosclerosis in a Model of Genetic Dyslipidemia and Intestinal Inflammation
por: Mencarelli, Andrea, et al.
Publicado: (2012)

The HIV Matrix Protein p17 Promotes the Activation of Human Hepatic Stellate Cells through Interactions with CXCR2 and Syndecan-2
por: Renga, Barbara, et al.
Publicado: (2014)

The Bile Acid Sensor FXR Is Required for Immune-Regulatory Activities of TLR-9 in Intestinal Inflammation
por: Renga, Barbara, et al.
Publicado: (2013)

The Bile Acid Sensor FXR Protects against Dyslipidemia and Aortic Plaques Development Induced by the HIV Protease Inhibitor Ritonavir in Mice
por: Mencarelli, Andrea, et al.
Publicado: (2010)

Use of maraviroc in patients with undetectable viral load: efficacy, tolerance and predictors of viral response in MARAVIROC-cohort study
por: Jesús Pérez Elías, María, et al.
Publicado: (2014)

Highly specific blockade of CCR5 inhibits leukocyte trafficking and reduces mucosal inflammation in murine colitis
por: Mencarelli, Andrea, et al.
Publicado: (2016)

Résultats cliniques des patients atteints de la COVID-19 au cours des études de phase IV sur la cladribine comprimés dans le traitement de la sclérose en plaques
por: Karan, Radmila, et al.
Publicado: (2021)

Cas d’infection à la COVID-19 chez des personnes atteintes de sclérose en plaques (SEP) traitées par ocrelizumab (OCR) : actualisation des données de pharmacovigilance
por: Hughes, Richard, et al.
Publicado: (2021)

CONFISEP : impact du confinement sur la prise en charge des patients atteints de sclérose en plaques
por: Guenot, Maëva, et al.
Publicado: (2021)

Sclérose en plaques et Covid-19 : étude d’une série de patients à l’ouest de l’Algérie
por: Bedrane, Zahira Barka, et al.
Publicado: (2022)

Association d’une démyélinisation centrale et périphérique subaiguë après une infection Sars-Cov-2
por: Verdier, Justine, et al.
Publicado: (2022)

Polyradiculonévrite aiguë et Covid-19 : à propos de 3 observations
por: Syrine, Lagha, et al.
Publicado: (2022)

Sclérose en plaques et Covid-19 : interactions entre les vaccins du Covid-19 et la Disease Modifying Therapy (DMT), étude d’une cohorte monocentrique
por: Kouki, Nesrine, et al.
Publicado: (2022)

Démyélinisation centrale et périphérique post Covid-19 : quels liens ?
por: Laroussi, Syrine, et al.
Publicado: (2022)

Sclérose en plaques et vaccination anti-Covid-19 : étude d’une cohorte de 37 patients
por: El Adraoui, Yassine, et al.
Publicado: (2022)

Une encéphalite dysimmune post-Covid mimant un syndrome de CLIPPERS extrapontique
por: Nouioua, Sonia, et al.
Publicado: (2022)

Anti-CD20 et sévérité de la COVID-19 chez les patients SEP : un impact différent chez les SEP rémittents et progressifs, dans la cohorte COVISEP
por: Januel, Édouard, et al.
Publicado: (2023)

Immunité cellulaire et humorale anti-SARS-CoV-2 chez les patients SEP traités par anti-CD20
por: Nicolas, Philippe, et al.
Publicado: (2023)

Réponses immunitaires au vaccin contre le virus SARS-CoV-2 et infections perthérapeutiques chez des personnes atteintes de sclérose en plaques (SEP) traitées par ocrélizumab (OCR)
por: Bar-Or, Amit, et al.
Publicado: (2023)

Impact de la vaccination ou de l’infection COVID-19 sur une cohorte de sujets présentant un syndrome radiologique isolé : l’étude VaxiRIS
por: Thomel-Rocchi, Océane, et al.
Publicado: (2023)

Safety and therapeutic efficacy of the switch to maraviroc+darunavir/ritonavir in HIV/HCV coinfected patients: initial results from GUSTA study
por: Gagliardini, Roberta, et al.
Publicado: (2014)

The effects of Maraviroc on liver fibrosis in HIV/HCV co-infected patients
por: Ortega Gonzalez, Enrique, et al.
Publicado: (2014)

Simplification to Stribild vs continuation of RTV-boosted DRV with FTC and TDF in virologically suppressed HIV adults: a STRATEGY-PI subgroup analysis
por: Arribas, Jose, et al.
Publicado: (2014)

Probiotics VSL#3 Protect against Development of Visceral Pain in Murine Model of Irritable Bowel Syndrome
por: Distrutti, Eleonora, et al.
Publicado: (2013)

Probiotics Modulate Intestinal Expression of Nuclear Receptor and Provide Counter-Regulatory Signals to Inflammation-Driven Adipose Tissue Activation
por: Mencarelli, Andrea, et al.
Publicado: (2011)

Outcomes After Posterior Cruciate Ligament (PCL) Reconstruction in Patients With Isolated and Combined PCL Tears
por: Mygind-Klavsen, Bjarne, et al.
Publicado: (2017)

Efficacy of a reduced dose of DARUNAVIR/RTV in a cohort of antiretroviral-naïve and experienced HIV-infected patients: a medium-term follow-up
por: Lanzafame, Massimiliano, et al.
Publicado: (2014)

The HIV matrix protein p17 induces hepatic lipid accumulation via modulation of nuclear receptor transcriptoma
por: Renga, Barbara, et al.
Publicado: (2015)

Bacteriophage isolation from human saliva: a pilot study with high school students
por: Nascimento, Teresa, et al.
Publicado: (2021)

Improvement of endothelial function after switching previously treated HIV-infected patients to an NRTI-sparing bitherapy with maraviroc
por: Bernal, Enrique, et al.
Publicado: (2014)

Long-term efficacy and safety of E/C/F/TDF vs EFV/FTC/TDF and ATV+RTV+FTC/TDF in HIV-1-infected treatment-naïve subjects ≥50 years
por: Gazzard, Brian, et al.
Publicado: (2014)

Maraviroc Intensification Modulates Atherosclerotic Progression in HIV-Suppressed Patients at High Cardiovascular Risk. A Randomized, Crossover Pilot Study
por: Francisci, Daniela, et al.
Publicado: (2019)

Dissociation of Intestinal and Hepatic Activities of FXR and LXRα Supports Metabolic Effects of Terminal Ileum Interposition in Rodents
por: Mencarelli, Andrea, et al.
Publicado: (2013)

Impaired Itching Perception in Murine Models of Cholestasis Is Supported by Dysregulation of GPBAR1 Signaling
por: Cipriani, Sabrina, et al.
Publicado: (2015)

Solomonsterol A, a Marine Pregnane-X-Receptor Agonist, Attenuates Inflammation and Immune Dysfunction in a Mouse Model of Arthritis
por: Mencarelli, Andrea, et al.
Publicado: (2013)

Bone mineral density improvement after 48 weeks of switch to maraviroc+darunavir/ritonavir 300/800/100 mg QD, preliminary results of GUSTA study
por: Bianco, Claudia, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_v73got988mn7lt1iud5mo71g2d